Cover Image
市場調查報告書

轉移性葡萄膜惡性黑色素瘤(Melanoma):全球臨床實驗檢討

Metastatic Uveal Melanoma Global Clinical Trials Review, H1, 2014

出版商 GlobalData 商品編碼 299731
出版日期 內容資訊 英文 95 Pages
訂單完成後即時交付
價格
Back to Top
轉移性葡萄膜惡性黑色素瘤(Melanoma):全球臨床實驗檢討 Metastatic Uveal Melanoma Global Clinical Trials Review, H1, 2014
出版日期: 2014年04月15日 內容資訊: 英文 95 Pages
簡介

本報告提供轉移性葡萄膜惡性黑色素瘤(Melanoma)的治療藥相關臨床實驗調查分析,臨床實驗數及被實驗人數,各階段及Phase別狀況,彙整有潛力的企業,正在開發的治療藥的資訊,臨床實驗簡介等,為您概述為以下內容。

目錄

簡介

各地區的臨床實驗

  • 各國臨床實驗趨勢
    • 亞太地區的主要國家
    • 歐洲的主要國家
    • 北美的主要國家
    • 中東·非洲的主要國家

G7各國的臨床實驗:腫瘤科臨床實驗上轉移性葡萄膜惡性黑色素瘤(Melanoma)的比例

G7各國的臨床實驗:Phase別

G7各國的臨床實驗:各階段

Phase別臨床實驗

各階段臨床實驗

未完成的臨床實驗

一定期間所採用的實驗對象

贊助商各類型臨床實驗

有潛力的贊助商

  • 參與轉移性葡萄膜惡性黑色素瘤(Melanoma)治療藥臨床實驗的主要企業

有前途藥物

最新臨床實驗新聞

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Novartis AG
    • AstraZeneca PLC
    • GlaxoSmithKline plc
    • Spectrum Pharmaceuticals, Inc.
  • 主要大學·研究機關·醫院臨床實驗概要
    • National Cancer Institute
    • The Clatterbridge Cancer Centre NHS Foundation Trust
    • The University of Texas M. D. Anderson Cancer Center
    • Alberta Health Services
    • Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital
    • Memorial Sloan Kettering Cancer Center
    • Ludwig-Maximilians-Universitat Munich
    • University Hospital, Essen
    • Barnes Retina Institute
    • University of California, Los Angeles

主要的臨床簡介

附錄

圖表

目錄
Product Code: GDHC2078CTIDB

GlobalData's clinical trial report, "Metastatic Uveal Melanoma Global Clinical Trials Review, H1, 2014" provides data on the Metastatic Uveal Melanoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Metastatic Uveal Melanoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Metastatic Uveal Melanoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Metastatic Uveal Melanoma
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Clinical Trials by G7 Countries: Proportion of Metastatic Uveal Melanoma to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Unaccomplished Trials of Metastatic Uveal Melanoma
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Metastatic Uveal Melanoma Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Metastatic Uveal Melanoma
    • Jun 01, 2013: AstraZeneca's New Therapy Selumetinib Improves Progression-Free Survival And Shrink Tumors In Metastatic Uveal Melanoma, Researchers Report
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Spectrum Pharmaceuticals, Inc.
      • Clinical Trial Overview of Spectrum Pharmaceuticals, Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • The Clatterbridge Cancer Centre NHS Foundation Trust
      • Clinical Trial Overview of The Clatterbridge Cancer Centre NHS Foundation Trust
      • The University of Texas M. D. Anderson Cancer Center
      • Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
      • Alberta Health Services
      • Clinical Trial Overview of Alberta Health Services
      • Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital
      • Clinical Trial Overview of Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital
      • Memorial Sloan Kettering Cancer Center
      • Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
      • Ludwig-Maximilians-Universitat Munich
      • Clinical Trial Overview of Ludwig-Maximilians-Universitat Munich
      • University Hospital, Essen
      • Clinical Trial Overview of University Hospital, Essen
      • Barnes Retina Institute
      • Clinical Trial Overview of Barnes Retina Institute
      • University of California, Los Angeles
      • Clinical Trial Overview of University of California, Los Angeles
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Metastatic Uveal Melanoma Therapeutics, Global, Clinical Trials by Region, 2014*
  • Metastatic Uveal Melanoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Metastatic Uveal Melanoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Metastatic Uveal Melanoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Metastatic Uveal Melanoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Metastatic Uveal Melanoma Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Metastatic Uveal Melanoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Proportion of Metastatic Uveal Melanoma to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Metastatic Uveal Melanoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Metastatic Uveal Melanoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Metastatic Uveal Melanoma Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Metastatic Uveal Melanoma Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Metastatic Uveal Melanoma Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Metastatic Uveal Melanoma Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Metastatic Uveal Melanoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Metastatic Uveal Melanoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Metastatic Uveal Melanoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Metastatic Uveal Melanoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Metastatic Uveal Melanoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Metastatic Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Metastatic Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014*
  • Metastatic Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Metastatic Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Spectrum Pharmaceuticals, Inc., 2014*
  • Metastatic Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014*
  • Metastatic Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The Clatterbridge Cancer Centre NHS Foundation Trust, 2014*
  • Metastatic Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014*
  • Metastatic Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Alberta Health Services, 2014*
  • Metastatic Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, 2014*
  • Metastatic Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014*
  • Metastatic Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Ludwig-Maximilians-Universitat Munich, 2014*
  • Metastatic Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Essen, 2014*
  • Metastatic Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Barnes Retina Institute, 2014*
  • Metastatic Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2014*

List of Figures

  • Metastatic Uveal Melanoma Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Metastatic Uveal Melanoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Metastatic Uveal Melanoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Metastatic Uveal Melanoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Metastatic Uveal Melanoma Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Proportion of Metastatic Uveal Melanoma to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Metastatic Uveal Melanoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Metastatic Uveal Melanoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Metastatic Uveal Melanoma Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Metastatic Uveal Melanoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Metastatic Uveal Melanoma Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Metastatic Uveal Melanoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Metastatic Uveal Melanoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Metastatic Uveal Melanoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Metastatic Uveal Melanoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Metastatic Uveal Melanoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top